No retraction, correction or concern found when last checked on Oct 27, 2026.
Damaged lung gas exchange function of discharged COVID-19 patients detected by hyperpolarized 129 Xe MRI
Haidong Li, Xiuchao Zhao, Yujin Wang and 10 more
Science Advances · 2021 · CC BY
Abstract
Functional imaging of the lungs in COVID-19 patients shows altered gas exchange function.
Full text
From PubMed Central, U.S. National Library of Medicine, as current on Oct 27, 2026. Paragraph numbers are ours, so an answer can point at one.
INTRODUCTION
In December of 2019, a novel coronavirus disease, COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan, China. The outbreak of COVID-19 posed a serious threat to global public health. On 11 March 2020, the World Health Organization (WHO) declared it a pandemic, and more than 7,823,289 cases have been confirmed in more than 200 countries and regions, including 431,541 deaths according to the WHO situation reports. In China, 78,377 discharged patients were reported to have recovered, of which about 81% showed mild and moderate symptoms and 14% of cases were considered to be severe. Only 5% of the patients presented acute symptoms.
COVID-19 is associated with symptoms of hypoxemia and shortness of breath as a result of pulmonary dysfunction. Autopsy results revealed white foam mucus in the trachea, gelatinous mucus attachment in the bronchus, pulmonary edema, and inflammation, indicating that hypoxemia may be related to the damaged pulmonary gas exchange function. In addition, vasculopathy and embolism have also been reported in COVID-19, stressing the importance of probing microstructure and function of the lungs at the alveolar-capillary interface. Pulmonary function tests (PFTs) such as FEV1 (forced expiratory volume in 1 s)/FVC (forced vital capacity) are used in the clinic to characterize the overall function of the lung. However, PFTs cannot probe vasculature at the alveolar-capillary interface within the lung.
X-ray computed tomography (CT) plays an important role in the diagnosis of lung disease by depicting the pulmonary structure. Many COVID-19–confirmed cases exhibit ground-glass opacities (GGOs) and extensive consolidation in the lungs. Although CT images provide high resolution for structural imaging of solid lung lesions, they are unable to evaluate the lung’s gas exchange function. The emerging technique of hyperpolarized (HP) 129Xe gas magnetic resonance imaging (MRI) can visualize and quantify both the lung’s microstructure and key functional parameters at the alveolar-capillary interface where gas exchange occurs. Such gas-phase MRI readouts have the potential of detecting the earliest signs of impairment in lung disease. Moreover, xenon gas MRI offers unique advantages for longitudinal studies, especially those involving children and pregnant women, thanks to the absence of ionizing radiation. Its feasibility and safety have been demonstrated in numerous clinical trials around China, United States, United Kingdom, Canada, and other countries. 129Xe MRI has yet to be evaluated in COVID-19 patients, and its potential for characterizing the disease remains unknown.
Here, we present the first 129Xe MRI study of discharged COVID-19 patients, aiming at quantitatively evaluating pulmonary gas exchange function and lung microstructure of those patients. We recruited a total of 25 subjects at the start of the outbreak in Wuhan, China—13 discharged COVID-19 patients and 12 healthy volunteers—and performed PFTs and HP xenon gas MRI on all the subjects to derive physiologically relevant parameters such as FEV1/FVC, ventilation defects percentage (VDP), exchange time constant (T), septal wall thickness (d), the ratio of xenon signal from red blood cells and interstitial tissue/plasma (RBC/TP), mean linear intercept (Lm), acinar duct radius (R), apparent diffusion coefficient (ADC), and surface-to-volume ratio (SVR). Furthermore, we analyzed the physiological parameters across the two groups and found that, although the lung microstructure appears similar to that of the healthy group, the pulmonary gas exchange function suggests impairment.
RESULTS
Table 1 summarizes subject data for the 13 discharged COVID-19 patients and 12 healthy subjects as collected upon admission, including demographic, epidemiological, laboratory tests, and clinical findings. Laboratory confirmation of COVID-19 was obtained upon admission to the hospital and subsequently verified by the Wuhan Center for Disease Control and Prevention (CDC). Clinical outcomes were monitored until 5 March 2020. The 13 adult COVID-19 patients were hospitalized in Tongji Hospital (Wuhan, China) before discharge. The admission date ranged from 19 January to 9 February, and the discharge time between 10 February and 5 March. The average age of the discharged patients was 35.8 years, ranging from 25 to 51 years (Table 1). The symptoms upon admission were typically fever, followed by cough and fatigue. Lymphocytopenia occurred in four (30.8%) patients, while six (46.2%) patients had elevated concentrations of high-sensitivity C-reactive protein (>10 mg/liter). Five (38.5%) patients had increased concentrations of alanine aminotransferase and aspartate aminotransferase. In addition, six (46.2%) patients had a normal white cell count, and six (46.2%) patients had a white cell count below the normal range. All patients had been treated in the isolation ward of Tongji Hospital and were deemed sufficiently recovered and discharged with an average hospital stay duration of 23 days.
Typical 129Xe MRI/magnetic resonance spectroscopy (MRS) data from representative discharged COVID-19 patient and healthy volunteer are shown in Fig. 1. VDPs derived from the xenon ventilation map are similar in the healthy subject (subject 6) and the discharged COVID-19 patient (patient 4): 1.5 and 1.6%, respectively. Microstructural parameters derived from the diffusion images, including Lm, R, ADC, and SVR, are comparable in both subjects. The gas exchange function parameters derived from the xenon recovery curves show substantial differences in the healthy subject versus the discharged patient: T = 23.5 ms versus 65.4 ms, d = 8.7 μm versus 14.6 μm, and RBC/TP = 0.282 versus 0.224.
Following antibiotic and antiviral therapies administered in hospital and isolation at home (average interval between the discharge and HP 129Xe gas MRI scan: 25 days), representative CT findings in COVID-19 patients (such as GGOs with/without reticular pattern and/or consolidation) at peak stage of COVID-19 pneumonia (Fig. 2) are unexpectedly well absorbed and even almost completely absorbed in some cases (Fig. 2). This would seem to suggest a substantial recovery in the group of discharged patients, at least according to measurements of the lung’s structure via CT.
Xenon gas MRI was then used to perform a more in-depth investigation of lung recovery, as described in Materials and Methods. Maps of lung ventilation distribution are generated and analyzed using a k-means clustering strategy in which voxel intensities across entire lungs are classified using one of five labels: no signal (denoting ventilation defects used to derive the VDP metric), hypointense, middle intense, middle high intense, and hyperintense signal. These five clusters are colored in red, brown, green, apple green, and blue, respectively, in Fig. 2. VDP is the percentage of those “ventilation defect” pixels across a given lung that was classified as “no signal.” The distribution of signal intensity from three representative patients is shown in Fig. 2, and the corresponding VDP for these patients are 1.6, 5.1, and 7.4%.
The chest CT scan of a patient acquired at the peak stage of COVID-19 pneumonia reveals multiple GGOs and/or partial consolidation in both the upper and lower lobes of bilateral lungs (Fig. 3). As a result of therapy, those lesions are substantially absorbed in the final scan, although light GGOs with unclear boundaries are still present in Fig. 3 (denoted by red circles). On the same day, the patient underwent an HP 129Xe gas MRI scan. The scan reveals signal intensity in the right lung that is lower than that in the left lung. In addition, ventilation in the regions denoted by green circles exhibits hypointense signal that also correlated with structural abnormalities caused by COVID-19 as measured by CT.
Table 2 shows quantitative results for the 13 discharged patients with COVID-19 (cov) and 12 healthy (h) volunteers, including measures of FEV1/FVC and %FEV1 with PFTs, ventilation function, lung morphometry parameters, and gas-blood exchange function with HP 129Xe gas MRI. Five of the 13 (38.5%) the discharged patients have VDP below 5%, and others have VDP within the interval [5%, 10%]. The mean (averaged across each group) VDP was 5.9% for COVID-19 patients and 3.7% for healthy volunteers. Statistical comparisons of VDP via unpaired Student’s t test show that COVID-19 patients are statistically different from the healthy volunteers (P = 0.0398). The lung morphometry and spirometry parameters in COVID-19 patients, including FEV1/FVC, %FEV1, R, Lm, SVR, and ADC, exhibit no statistically significant differences compared with those of the healthy group. For the discharged patient group, all FEV1/FVC values of patients are consistently above 0.70 (see Table 2). The patient-averaged FEV1/FVC value obtained in this study (0.83) is comparable to values reported in the literature for healthy (0.70 in North America, Europe, and China) and subjects with COPD (chronic obstructive pulmonary disease) (<0.70 in North America, Europe, and China). This patient-averaged FEV1/FVC value is also similar to the average value that we measured in healthy subjects (0.83). As for the physiological parameters related to gas-blood exchange function measured by HP gas MRI, namely, T, d, and RBC/TP, all show statistically significant differences (P < 0.05) between the two groups (h versus cov). In the discharged patients with COVID-19, T and d are higher [43.5 ms (cov) versus 32.0 ms (h), and 11.7 μm (cov) versus 10.1 μm (h), respectively], while RBC/TP is reduced [0.279 (cov) versus 0.330 (h)] when compared with that in healthy volunteers. Quantitative results for each healthy subject are summarized in table S1.
DISCUSSION
As an emerging technique for quantifying pulmonary function in pulmonary diseases, the feasibility of HP xenon gas MRI in evaluating gas exchange function and microstructural parameters of the lung has been demonstrated in multiple clinical studies. However, none of them have dealt with COVID-19 patients. By using HP xenon gas MRI, hypoxemia in a COVID-19 patient caused by poor ventilation or gas exchange or both can be determined. Here, the effects of COVID-19 on the lungs of discharged patients have been evaluated. The average VDP of the discharged patients was 5.9%, which is significantly larger than that in healthy subjects (3.7%). We note that all recovered patients had a VDP of less than 10%. The statistical differences between the discharged and healthy subjects (P = 0.0398) meant that the lesions after absorption (e.g., light GGOs) may have an effect on ventilation function. This is evident in Fig. 3, where the location of lesions (red circles) exhibited low signal intensity in the ventilation maps. Such a detailed assessment of lung function is not currently possible by PFT.
We also evaluate pulmonary morphological parameters using diffusion-weighted MRI (DW-MRI). We recorded microstructural parameters of the pulmonary acinus, which are the largest lung units involved in pulmonary gas exchange, located at the distal end of the terminal bronchioles. The measured ADC, R, Lm, and SVR in discharged patients have values similar to those of healthy subjects. Morphological parameters are also found to be within normal ranges in some discharged patients that had GGO(s) visible in their final CT scan. HP 129Xe gas MRI was used to image the alveolar airspace. The pulmonary morphological parameters were derived on the basis of the diffusion properties of xenon gas in the alveoli. Our results indicate that the alveolar microstructure for gas diffusion did not appear affected in most COVID-19 patients after treatment (recalling that our COVID-19 patients had moderate condition).
One of the sequelae of SARS is pulmonary fibrosis. The gas exchange function parameters T, d, and RBC/TP measured with HP 129Xe MR were found significantly different between healthy subjects and patients with interstitial lung diseases (ILDs) such as pulmonary fibrosis. Recent studies revealed that the pathological features of COVID-19 are similar to those of SARS; for example, in SARS, interstitial mononuclear inflammatory infiltrates and fibroblastic proliferation of alveolar septum are also found in the lung. In our study, we found that T and d were 35.9 and 15.8% higher, respectively, whereas RBC/TP was 17.8% lower in discharged patients (relative to healthy subjects). Those observations are similar to the trends observed in patients with ILD. On the basis of a simple comparison of two time points in four discharged patients (fig. S2 and table S2), we attribute them to the interstitial thickening and perfusion deficits caused by inflammation and possible fibrosis during the patients’ recovery stage, which would be expected to increase upon xenon uptake and slow down the transfer of xenon from alveoli to RBCs. The relatively preserved lung function and lack of microstructural damage in discharged COVID-19 patients may be attributed to the relatively young age of the discharged patients (average age, 35.8 years). Our results suggest that the pulmonary function parameters obtained using HP gas MRI are more sensitive for the evaluation of pulmonary injuries caused by COVID-19 than PFT and CT combined, in particular the parameters related to gas exchange function. (The measured d in this study is a “functional” septal wall thickness, not the morphological one.)
This study shows that HP 129Xe MRI offers a unique advantage in evaluating pulmonary function damage caused by COVID-19. X-ray CT, which has played a critical role in the diagnosis and monitoring of therapy for the COVID-19 global health emergency, features high accuracy and short scan times. According to patient discharge criteria in China, lesions in representative CT lung scans (e.g., GGOs and/or consolidation in Fig. 2) for discharged patients should be substantially absorbed. After more than 14 days of isolation, those structural abnormalities are further (and in a case, almost completely) absorbed. Nevertheless, there are large differences among the three patients with regard to both ventilation function (e.g., VDP of 1.6, 5.1, and 7.4%) and gas-blood exchange function (e.g., T, d, and RBC/TP) of the lung, yet little difference in the microstructural parameters. These findings indicate that compared with lung structure, gas-blood exchange function of the lung may require a longer time to recover, and the technique of HP 129Xe gas MRI here is critical in providing this type of assessment.
HP gas MRI scans were typically carried out a few days following the corresponding final CT scans, except for subject 2, who underwent both MRI and CT scans on the same day. For subject 2, multiple GGOs in the upper and lower lobes of bilateral lungs are significantly enlarged (Fig. 3), relative to the initial CT images, which meant that the absorption of structural abnormalities would be expected to require more time because of the presence of multiple light GGOs in the left upper and lower lobes of bilateral lungs with unclear boundaries (Fig. 3). HP 129Xe gas MRI reveals that the lesions in Fig. 3 had low signal intensity. By combining HP gas MRI with the corresponding CT images, the physician is provided with a comprehensive picture of the lung state based not only on microstructural information (e.g., size, location, and morphological features of lesions) but also on gas exchange function (e.g., ventilation, gas-blood exchange, and microstructure parameters). Xenon images provide unique information about the lung function that is absent from structural images. The correlation between structure and function remains unclear: Patients that appear to have recovered based on CT scans may still have impaired lung function according to the ventilation maps. In these cases, xenon MRI is able to quantify the extent and nature of the functional impairment and is expected to be helpful for prognosis and monitoring of COVID-19 disease progression (e.g., the enlargement or absorption of GGOs and/or consolidation and the recovery of lung structure and function).
Our research can be further expanded, since xenon MRI scans only performed on the participants at a single point in time (upon discharge). It would be interesting to perform longitudinal studies on those patients to assess recovery over the long term. This study only probed gas exchange on the whole lung. To better understand the local functional impairment, regional thickening of the interstitial tissue barrier and regional defects in RBCs should be the subject of future studies. Last, we used a flexible vest radio frequency (RF) coil to collect the MRI data. Such coils exhibit a moderate amount of B1 inhomogeneity, namely, signal loss near the edges of the coil (such as at the apex of the lung). To evaluate the ventilation defects quantitatively within a specific patient group, coils with more homogeneous B1 distribution and an improved bias field correction algorithm may be helpful.
In summary, we evaluated the pulmonary gas exchange function and microstructural parameters in 13 COVID-19 discharged patients with moderate symptoms using the imaging technique HP 129Xe gas MRI. We found statistically significant differences in T, d, VDP, and RBC/TP between the cohorts, highlighting the power of xenon MRI in evaluating lung injury caused by COVID-19. HP 129Xe gas MRI could be a powerful supplement to chest CT in evaluating the lung’s gas exchange function in COVID-19 patients and may be useful in longitudinal follow-ups of patients during progress of disease and subsequent recovery of lung function.
MATERIALS AND METHODS
According to the Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (seventh edition) issued by the National Health Commission of China, clinical classifications are divided into mild, moderate, severe, and critically severe symptoms. According to the guide’s discharge standard, patients that meet the following conditions can be discharged: (i) The body temperature returns to normal for more than three consecutive days; (ii) significant improvement of the respiratory symptoms; (iii) pulmonary CT images showing significant improvement of the acute exudative lesions; (iv) and negative nucleic acid test results of sputum, nasopharynx swab, and other respiratory samples for two consecutive tests (with sampling time at least 1 day apart). A total of 13 COVID-19 pneumonia discharged patients (4 men and 9 women, average age is 35.8 years) with moderate symptoms were recruited for our study. All patients had been laboratory confirmed for COVID-19 when first admitted to the hospital and subsequently verified by the Wuhan CDC. They have no history of lung disease and smoking, and lung health was also confirmed by chest x-ray examination, which was performed in the annual physical examination (year 2019). Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for these discharged patients, who were admitted to Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. We also recruited 12 healthy volunteers with an average age of 32.5 years (range, 24 to 40 years) as the control group. Our study was approved by the Ethics Commission of Tongji Medical College, Huazhong University of Science and Technology, and all subjects signed the informed consent forms.
Final CT scans were obtained with patients in the supine position (11 patients underwent scanning after discharge, and two patients underwent scanning shortly before discharge) using one of the three CT systems: LightSpeed 16 or volume CT, GE Healthcare, Wisconsin, USA (9/13); Somatom Definition AS+, Siemens, Germany (2/13); and uCT 780, United Imaging, China (2/13). The following parameters were used: tube voltage = 100 to 120 kilovolt peak, matrix = 512 × 512, slice thickness = 1.00 to 1.25 mm, and field of view (FOV) = 350 mm × 350 mm. The tube current was regulated through an automatic exposure modulation system, and the single collimation width of reconstructed images was 0.50 to 1.25 mm.
All MRI scans were performed using a 3.0-T multinuclear whole-body MRI Scanner [uMR780(Xe), Wuhan, China] with a horizontal magnet using a transmit-receive vest RF coil (35.45 MHz for 129Xe). HP 129Xe was produced with the spin-exchange optical pumping technique using a commercial polarizer system (verImagin Healthcare, Wuhan, China), with a freeze-out accumulation procedure in a cold finger. A gas mixture of 2% enriched xenon (86% 129Xe isotope), 88% 4He, and 10% N2 was used in this study. After the xenon accumulation process, HP gas was thawed using hot water and extracted into a 1-liter Tedlar bag, which was purged to approximately 9 Pa with a vacuum pump. The available spin polarization of 129Xe gas in the Tedlar bag was approximately 25%. Before the magnetic resonance (MR) experiments, the subject inhaled 1 liter of gas mixture (5% xenon + 95% N2) from the functional residual capacity (FRC) to calibrate the flip angle. Afterward, the subject inhaled 1 liter of gas mixture (40% xenon + 60% N2) from the FRC for measuring pulmonary ventilation function, gas exchange function, and microstructure parameters, respectively. For each patient, a total of four bags of xenon gas were used. The patients were kept in the MRI scanner for less than 15 min; for each xenon MRI scan, the duration was less than 15 s.
Pulmonary ventilation function was assessed using HP 129Xe gas MRI. The MRI scans were performed on each subject using a three-dimensional balanced steady-state free precession sequence with FOV = (38 cm)2, matrix = 96 × 84, slice number = 20, slice thickness = 9 mm, bandwidth = 800 Hz per pixel, flip angle = 12° to 14°, and repetition time/echo time = 5.6/2.65 ms. Proton images of the thoracic cavity for matching were also acquired using the 1H body coil after the 129Xe MRI scan during the same breath-hold. Proton MRI scans were acquired using a fast-spoiled gradient-echo sequence with FOV = (38 cm)2, matrix = 96 × 48 (partial echo = 82%), number of slices = 20, slice thickness = 9 mm, bandwidth = 800 Hz per pixel, flip angle = 20°, and repetition time/echo time = 4.5/2.2 ms. All 129Xe gas and proton images were reconstructed to a 96 × 96 matrix for purposes of calculating the ventilation defects. In this study, we did not perform a retrospective bias field correction, which has been used by other groups for correcting B1 inhomogeneity, because these corrections often inadvertently remove intensity nonuniformity caused by physiological changes. The technique of HP 129Xe chemical shift saturation recovery (CSSR) was used to obtain the gas-blood exchange functional parameters of the lung by the model of xenon exchange (MOXE) using a dissolved-phase 129Xe diffusion coefficient of 3.3 × 10−6 cm2 s−1. For the CSSR data collection, 21 exchange time points ranging from 10 to 700 ms were used, and the spectra were acquired using a 90° RF pulse with a bandwidth of 50 Hz per points and 1024 sampling points. The bottom part of Fig. 4 shows the physiological parameters, including T, d, and blood hematocrit (Hct). The ratio of xenon signal from RBCs and xenon signal from interstitial TP at an exchange time of 100 ms was calculated (RBC/TP). HP 129Xe DW-MRI images were used to derive the pulmonary microstructure parameters. DW-MRI scans were acquired for four b values (0, 10, 20, and 30 s/cm2) using interleaved sampling and acquisition parameters: FOV = (38 cm)2, matrix = 64 × 32, slice number = 4, slice thickness = 30 mm, bandwidth = 600 Hz per pixel, flip angle = 8° to 11°, and repetition time/echo time = 15.5/12.5 ms. As shown in the top part of Fig. 4, the pulmonary morphometric parameters, including R, Lm, and SVR, were extracted by fitting the DW-MRI data to the anisotropic diffusion model of the 129Xe diffusion pixel by pixel using a nonlinear least squares algorithm after reconstructing the images to 64 × 64 matrix. PFTs were performed on the same day as the MRI scans using a handheld spirometer (sp-1, Schiller AG, Switzerland). MRI-derived microstructural parameters R, Lm, SVR, and ADC were computed as maps (i.e., on a pixel-by-pixel basis); however, the values reported in this article are volume averaged over the patient’s lungs, and the error bars cited are SDs over the same region.
References 37
- 1.
Chinese Center for Disease Control and Prevention, Distribution of coronavirus disease 2019 (2020); http://2019ncov.chinacdc.cn/2019-nCoV/.
Not in our library
- 2.
Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054–1062 (2020 ).
Not in our library10.1016/s0140-6736(20)30566-3
- 3.
Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang L., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 395, 507–513 (2020 ).
Not in our library10.1016/s0140-6736(20)30211-7
- 4.
Cohen J., Scientists are racing to model the next moves of a coronavirus that’s still hard to predict. Science 10.1126/science.abb2161, (2020 ).
Not in our library
- 5.
World Health Organization, Coronavirus disease 2019 (COVID-19) situation report–147 (2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200615-covid-19-sitrep-147.pdf?sfvrsn=2497a605_4.
Not in our library
- 6.
National Health Commission of the People’s Republic of China, Update on COVID-19 as of 24:00 on 15 June 2020 (2020); www.nhc.gov.cn/xcs/yqtb/202006/9579b16df7654ce6bee3b446d071d79a.shtml.
Not in our library10.46234/ccdcw2020.082
- 7.
Mehta P., McAuley D. F., Brown M., Sanchez E., Tattersall R. S., Manson J. J.; HLH Across Speciality Collaboration, UK, COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033–1034 (2020 ).
Not in our library10.1016/s0140-6736(20)30628-0
- 8.
Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., Niu P., Zhan F., Ma X., Wang D., Xu W., Wu G., Gao G. F., Phil D., Tan W.; China Novel Coronavirus Investigating and Research Team, A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020 ).
Not in our library10.1056/nejmoa2001017
- 9.
Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., Bi Y., Ma X., Zhan F., Wang L., Hu T., Zhou H., Hu Z., Zhou W., Zhao L., Chen J., Meng Y., Wang J., Lin Y., Yuan J., Xie Z., Ma J., Liu W. J., Wang D., Xu W., Holmes E. C., Gao G. F., Wu G., Chen W., Shi W., Tan W., Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet 395, 565–574 (2020 ).
Not in our library10.1016/s0140-6736(20)30251-8
- 10.
Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L., Tai Y., Bai C., Gao T., Song J., Xia P., Dong J., Zhao J., Wang F.-S., Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 8, 420–422 (2020 ).
Not in our library10.1016/s2213-2600(20)30076-x
- 11.
Ackermann M., Verleden S. E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W. W., Li V. W., Mentzer S. J., Jonigk D., Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 383, 120–128 (2020 ).
Not in our library10.1056/nejmoa2015432
- 12.
Shi H., Han X., Jiang N., Cao Y., Alwalid O., Gu J., Fan Y., Zheng C., Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study. Lancet Infect. Dis. 20, 425–434 (2020 ).
Not in our library10.1016/s1473-3099(20)30086-4
- 13.
Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q., Liao J., Yang H., Hou W., Zhang Y., Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 395, 809–815 (2020 ).
Not in our library10.1016/s0140-6736(20)30360-3
- 14.
Albert M. S., Cates G. D., Driehuys B., Happer W., Saam B., Springer C. S., Wishnia A., Biological magnetic resonance imaging using laser-polarized 129Xe. Nature 370, 199–201 (1994 ).
Not in our library10.1038/370199a0
- 15.
Culver B. H., Graham B. L., Coates A. L., Wanger J., Berry C. E., Clarke P. K., Hallstrand T. S., Hankinson J. L., Kaminsky D. A., MacIntyre N. R., Mc Cormack M. C., Rosenfeld M., Stanojevic S., Weiner D. J., Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement. Am. J. Respir. Crit. Care Med. 196, 1463–1472 (2017 ).
Not in our library10.1164/rccm.201710-1981st
- 16.
Chang Y. V., MOXE: A model of gas exchange for hyperpolarized 129Xe magnetic resonance of the lung. Magn. Reson. Med. 69, 884–890 (2013 ).
Not in our library10.1002/mrm.24304
- 17.
Kaushik S. S., Freeman M. S., Yoon S. W., Liljeroth M. G., Stiles J. V., Roos J. E., Foster W. S. M., Rackley C. R., McAdams H. P., Driehuys B., Measuring diffusion limitation with a perfusion-limited gas—Hyperpolarized 129Xe gas-transfer spectroscopy in patients with idiopathic pulmonary fibrosis. J. Appl. Physiol. 117, 577–585 (2014 ).
Not in our library10.1152/japplphysiol.00326.2014
- 18.
Zhang H., Xie J., Xiao S., Zhao X., Zhang M., Shi L., Wang K., Wu G., Sun X., Ye C., Zhou X., Lung morphometry using hyperpolarized 129Xe multi-b diffusion MRI with compressed sensing in healthy subjects and patients with COPD. Med. Phys. 45, 3097–3108 (2018 ).
Not in our library10.1002/mp.12944
- 19.
Rayment J. H., Couch M. J., McDonald N., Kanhere N., Manson D., Santyr G., Ratjen F., Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis. Eur. Respir. J. 53, 1802188 (2019 ).
Not in our library10.1183/13993003.02188-2018
- 20.
Mugler J. P. III, Altes T. A., Ruset I. C., Dregely I. M., Mata J. F., Miller G. W., Ketel S., Ketel J., Hersman F. W., Ruppert K., Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129. Proc. Natl. Acad. Sci. U.S.A. 107, 21707–21712 (2010 ).
Not in our library10.1073/pnas.1011912107
- 21.
Driehuys B., Martinez-Jimenez S., Cleveland Z. I., Metz G. M., Beaver D. M., Nouls J. C., Kaushik S. S., Firszt R., Willis C., Kelly K. T., Wolber J., Kraft M., McAdams H. P., Chronic obstructive pulmonary disease: Safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients. Radiology 262, 279–289 (2012 ).
Not in our library10.1148/radiol.11102172
- 22.
Duan C., Deng H., Xiao S., Xie J., Li H., Sun X., Ma L., Lou X., Ye C., Zhou X., Fast and accurate reconstruction of human lung gas MRI with deep learning. Magn. Reson. Med. 82, 2273–2285 (2019 ).
Not in our library10.1002/mrm.27889
- 23.
Stewart N. J., Leung G., Norquay G., Marshall H., Parra-Robles J., Murphy P. S., Schulte R. F., Elliot C., Condliffe R., Griffiths P. D., Kiely D. G., Whyte M. K., Wolber J., Wild J. M., Experimental validation of the hyperpolarized 129Xe chemical shift saturation recovery technique in healthy volunteers and subjects with interstitial lung disease. Magn. Reson. Med. 74, 196–207 (2015 ).
Not in our library10.1002/mrm.25400
- 24.
Hon K. L. E., Leung C. W., Cheng W. T. F., Chan P. K. S., Chu W. C. W., Kwan Y. W., Li A. M., Fong N. C., Ng P. C., Chiu M. C., Li C. K., Tam J. S., Fok T. F., Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet 361, 1701–1703 (2003 ).
Not in our library10.1016/s0140-6736(03)13364-8
- 25.
Weatherley N. D., Stewart N. J., Chan H.-F., Austin M., Smith L. J., Collier G., Rao M., Marshall H., Norquay G., Renshaw S. A., Bianchi S. M., Wild J. M., Hyperpolarised xenon magnetic resonance spectroscopy for the longitudinal assessment of changes in gas diffusion in IPF. Thorax 74, 500–502 (2019 ).
Not in our library10.1136/thoraxjnl-2018-211851
- 26.
Wu J. H., Li X., Huang B., Su H., Li Y., Luo D. J., Chen S., Ma L., Wang S. H., Nie X., Peng L., Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: Report of 10 cases by postmortem needle autopsy. Chin. J. Pathol. 49, 568–575 (2020 ).
Not in our library10.3760/cma.j.cn112151-20200405-00291
- 27.
Tian S., Hu W., Niu L., Liu H., Xu H., Xiao S.-Y., Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J. Thorac. Oncol. 15, 700–704 (2020 ).
Not in our library10.1016/j.jtho.2020.02.010
- 28.
Ai T., Yang Z., Hou H., Zhan C., Chen C., Lv W., Tao Q., Sun Z., Xia L., Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: A report of 1014 cases. Radiology 296, E32–E40 (2020 ).
Not in our library10.1148/radiol.2020200642
- 29.
China National Health Commission, Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition) (2020); www.nhc.gov.cn/xcs/zhengcwj/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.
Not in our library
- 30.
Wang J. M., Robertson S. H., Wang Z., He M., Virgincar R. S., Schrank G. M., Smigla R. M., O’Riordan T. G., Sundy J., Ebner L., McAdams P., Driehuys B., Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis. Thorax 73, 21–28 (2018 ).
Not in our library10.1136/thoraxjnl-2017-210070
- 31.
Zanette B., Santyr G., Accelerated interleaved spiral-IDEAL imaging of hyperpolarized 129Xe for parametric gas exchange mapping in humans. Magn. Reson. Med. 82, 1113–1119 (2019 ).
Not in our library10.1002/mrm.27765
- 32.
Qing K., Mugler J. P. III, Altes T. A., Jiang Y., Mata J. F., Miller G. W., Ruset I. C., Hersman F. W., Ruppert K., Assessment of lung function in asthma and COPD using hyperpolarized 129Xe chemical shift saturation recovery spectroscopy and dissolved-phase MRI. NMR Biomed. 27, 1490–1501 (2014 ).
Not in our library10.1002/nbm.3179
- 33.
Tustison N. J., Avants B. B., Cook P. A., Zheng Y., Egan A., Yushkevich P. A., Gee J. C., N4ITK: Improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310–1320 (2010 ).
Not in our library10.1109/tmi.2010.2046908
- 34.
Tustison N. J., Altes T. A., Song G., de Lange E. E., Mugler J. P. III, Gee J. C., Feature analysis of hyperpolarized helium-3 pulmonary MRI: A study of asthmatics versus nonasthmatics. Magn. Reson. Med. 63, 1448–1455 (2010 ).
Not in our library10.1002/mrm.22390
- 35.
He M., Kaushik S. S., Robertson S. H., Freeman M. S., Virgincar R. S., McAdams H. P., Driehuys B., Extending semiautomatic ventilation defect analysis for hyperpolarized 129Xe ventilation MRI. Acad. Radiol. 21, 1530–1541 (2014 ).
Not in our library10.1016/j.acra.2014.07.017
- 36.
Zhou X., Graziani D., Pines A., Hyperpolarized xenon NMR and MRI signal amplification by gas extraction. Proc. Natl. Acad. Sci. U.S.A. 106, 16903–16906 (2009 ).
Not in our library10.1073/pnas.0909147106
- 37.
Sukstanskii A. L., Yablonskiy D. A., Lung morphometry with hyperpolarized 129Xe: Theoretical background. Magn. Reson. Med. 67, 856–866 (2012 ).
Not in our library10.1002/mrm.23056
Cited by papers we hold 2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.